Virtual study designs are transforming the way biopharmaceutical businesses conduct research. Tactics that decentralize the approach to clinical and observational research are ushering in a new paradigm of efficient data collection and patient-centric engagement.
Join UBC’s Biopharmaceutical industry experts, Aaron Berger, Senior Director, Safety, Epidemiology, Registries & Risk Management, Nancy Mulligan, Executive Director, Patient & Physician Services, Bruce Smith (advisory), Executive Director, Scientific & Operational Strategy, and former staff member, Megan White, Supervisor, Program Management, as they take a wide-lensed view of virtual study designs. They discuss ways VSD impact improved data collection and enhances patient engagement. Click below to access the webinar and visit here for more information on our expertise in virtual and decentralized trials.
Watch the full webinar here.